Experts recommend eating foods high in probiotics before taking a supplement for weight loss, but supplements can help fill ...
A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...
A woman who ran two weight loss clinics in the Pittsburgh area is charged in federal court with mislabeling animal medication ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
Costco now is selling Ozempic and Wegovy at discounted prices, a move that expands access to the popular weight-loss drugs. Costco members with prescriptions can purchase the drugs out-of-pocket for ...
Amy Schumer is showing off her figure. The Trainwreck star debuted a slimmer frame during a recent girls’ trip to Las Vegas with pals Jillian Bell and Alex Saks. In a photo posted on Instagram Oct. 4, ...
Amid the surge in GLP-1 weight-loss medications, some have questioned whether invasive procedures like lap band, gastric sleeve and bypass surgeries could wane in popularity. Carnie Wilson, of the ...
Andy Cohen has been sporting a trimmer figure in recent months, but the Bravo TV host is more focused on his health than the number on the scale. While appearing on “TODAY with Jenna & Friends” on ...
These players are vying for positions in the billion-dollar weight loss drug market. Demand for weight loss drugs is soaring, suggesting there's room for more than one winner. Investors once ...
Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug companies and insurers over their costs, leaving them without coverage even as ...
After abandoning the development of an oral weight-loss drug, Pfizer is getting back in the game. The US pharma giant has agreed to buy Metsera, which is developing a range of weight-loss drugs, for ...
Pfizer PFE-0.20%decrease; red down pointing triangle has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera MTSR-0.27%decrease; red down pointing triangle in a deal that gets the ...